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Beware of ligand efficiency (LE): 
understanding LE data in modeling 
structure-activity and structure-economy 
relationships
Jaroslaw Polanski*, Aleksandra Tkocz and Urszula Kucia
Abstract 
Background: On the one hand, ligand efficiency (LE) and the binding efficiency index (BEI), which are binding prop-
erties (B) averaged versus the heavy atom count (HAC: LE) or molecular weight (MW: BEI), have recently been declared 
a novel universal tool for drug design. On the other hand, questions have been raised about the mathematical validity 
of the LE approach.
Results: In fact, neither the critics nor the advocates are precise enough to provide a generally understandable and 
accepted chemistry of the LE metrics. In particular, this refers to the puzzle of the LE trends for small and large mol-
ecules. In this paper, we explain the chemistry and mathematics of the LE type of data. Because LE is a weight metrics 
related to binding per gram, its hyperbolic decrease with an increasing number of heavy atoms can be easily under-
stood by its 1/MW dependency. Accordingly, we analyzed how this influences the LE trends for ligand-target binding, 
economic big data or molecular descriptor data. In particular, we compared the trends for the thermodynamic ∆G 
data of a series of ligands that interact with 14 different target classes, which were extracted from the BindingDB data-
base with the market prices of a commercial compound library of ca. 2.5 mln synthetic building blocks.
Conclusions: An interpretation of LE and BEI that clearly explains the observed trends for these parameters are pre-
sented here for the first time. Accordingly, we show that the main misunderstanding of the chemical meaning of the 
BEI and LE parameters is their interpretation as molecular descriptors that are connected with a single molecule, while 
binding is a statistical effect in which a population of ligands limits the formation of ligand-receptor complexes. There-
fore, LE (BEI) should not be interpreted as a molecular (physicochemical) descriptor that is connected with a single 
molecule but as a property (binding per gram). Accordingly, the puzzle of the surprising behavior of LE is explained by 
the 1/MW dependency. This effect clearly explains the hyperbolic LE trend not as a real increase in binding potency 
but as a physical limitation due to the different population of ligands with different MWs in a 1 g sample available for 
the formation of ligand-receptor complexes.
Keywords: Ligand efficiency, Ligand-target binding affinity, Fragmental metrics, Weight metrics, Molar metrics, 
Avogadro number, Big data
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Background
Ligand efficiency (LE), which is the free energy of bind-
ing (B) averaged versus the heavy atom count (HAC), has 
recently been declared to be a novel universal tool for 
drug design that will permit the substantial optimization 
of both molecular mass and lipophilicity by ameliorating 
the inflation of these properties that has been observed in 
current medicinal chemistry practice and to increase the 
quality of drug candidates [1]. As this effect may have 
resulted from the application of current procedures that 
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are based on the common use of  IC50 or binding affinity 
 (Ki) in drug optimization, the efficiency approach appears 
to be especially attractive in controlling both the molar 
binding potency and HAC or molecular weight (MW) at 
the same time.
However, questions have recently been raised about 
the mathematical validity of the definition of LE [2–4]. 
Specifically, for example, as indicated by the anony-
mous reviewer of the first version of this publication: 
LE, whether derived from deltaG, Kd, Ki, or IC50, has an 
arbitrary 1  M concentration unit built into it. Changing 
this unit will, in general, result in a change in the per-
ception of efficiency. Therefore, the dependence of LE, e.g. 
derived from deltaG, on the concentration used to define 
the standard state implies that LE derived from deltaG 
is thermodynamically meaningless. However, despite 
the fact that although the con arguments were basically 
introduced as early as 2009 [4], the situation is still not 
clear, just to cite a recent discussion. In the Ref. [5] we 
read: LE […] widely used to normalize potency for size, 
does not, in fact, normalize potency for size. LE decreases 
and appears to plateau as size, or number of heavy atoms, 
increases. Several plausible hypotheses were proposed to 
explain this observation in terms of ligand flexibility and/
or entropic penalties, reduced surface area available for 
interaction, target specific restrictions and size-dependent 
complexity that reduced the probability of optimal fitting. 
The answer requires a simple example of fuel efficiency 
to justify the mathematics of LE trends [6]. In fact, nei-
ther the critics nor the advocates were precise enough to 
provide any understandable mathematics or chemistry of 
the LE metrics. Moreover, because these parameters are 
in common use as early estimators for drug optimization, 
apparently the numerous con arguments appeared to be 
not convincing enough for the drug design audience. The 
reason is that this allowed for the understanding of the 
mathematical or chemical inaccuracies; however, they 
have never cleared the reason for the observed puzzle of 
the LE (BEI) hyperbolic trend explicitly enough. Because 
the trend obviously indicates an advantage in binding 
efficiency for the small molecules, which is both attrac-
tive and expected in drug design, the LE (BEI) approach 
has become more and more popular in academia and 
pharma drug design.
Herein, we show that the basis for the LE (BEI) puz-
zle can be cleared up by a careful analysis of its chemical 
meaning. Accordingly, we demonstrated that the main 
misunderstanding of the chemical meaning of the BEI 
and LE parameters is their interpretation as molecular 
descriptors that are connected with a single molecule, 
whereas binding is a statistical effect in which a popu-
lation of ligands is an important factor that determines 
the pairing of ligand-receptor complexes. Therefore, LE 
(BEI) should not be interpreted as molecular (physico-
chemical) descriptors (binding per Dalton) but as statis-
tical properties (BEI—binding per gram, where a gram 
is a mole of Daltons); (LE—binding per a mole of HAC). 
Accordingly, the puzzle of the surprising behavior of LE 
is explained by the 1/MW dependency of a 1 g substance 
of molecules that have the MW, which is a property that 
can be measured. This effect clearly explains the hyper-
bolic LE trend not as the real increase in binding potency 
but by the availability of ligands for the ligand-receptor 
complexes. Additionally, we analyzed the LE-type inten-
sive parameters including a broad spectrum of both 
molecular descriptors and properties. We demonstrated 
that individual LE trends can be explained by the basic 
rules of chemistry, thereby indicating how important it is 
to distinguish between molecular descriptors and prop-
erties [7, 8]. More specifically, we compared two datasets. 
The first was the experimental binding thermodynamics 
for approximately 100 protein–ligand complexes [9]. The 
second was the big data of the market prices of a large 
commercial library of building blocks [10].
Methods
Molecular descriptors versus properties
Basically, chemical compounds, i.e. both molecules and 
substances, can be represented by molecular descriptors, 
i.e. indicators that relate to the molecule or molecular 
structure that can be calculated from a molecular rep-
resentation or by the properties that are to be measured 
experimentally if there are real values or that require 
predictions during molecular design [7]. However, it is 
not always easy to distinguish between these two data 
types. Let us analyze molecular weight (MW). It can 
be a property when measured for molecules, e.g. in MS 
spectrometry or even when we are weighting a mole, i.e. 
the Avogadro number of the molecules or its fraction, 
but alternatively it can also be a descriptor when we are 
estimating the MW of a single molecule simply by sum-
ming the atomic mass contributions to the total MW. The 
weight of 1  mol of a substance will be its MW (g/mol), 
while the weight of a single molecule will be its MW (Da). 
The correlation between these two variables is 100% and 
creates a major trick in chemistry when we are mapping 
substances to molecules and vice versa. In fact, we need 
an Avogadro number  (NA), which is a chemical routine, 
for this transformation that is generally overlooked. 
Therefore, MW (Da) * NA = MW (g/mol).
LE definitions and metrics
Formal definitions of ligand and binding efficiency LE 
and BEI have previously been described in the litera-
ture and various forms of these parameters were pre-
cisely described by Cortes-Ciriano recently [11]. We will 
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interpret these parameters in their widest sense as given 
below:
where the binding property is any property that is meas-
ured in order to define the interactions between a ligand 
and a receptor and HAC is the heavy (nonhydrogen) 
atom count.
where the binding property is any property that is meas-
ured in order to define the interactions between a ligand 
and a receptor and MW corresponds to the molecular 
weight in Daltons (Da).
Generally, in the literature both LE and BEI are inter-
preted as molecular descriptors in the sense of phys-
icochemical descriptors, for BEI compare especially 
Cortes-Ciriano [11] and Abad-Zapatero et al. [12]. In the 
context of the differentiation of the molecular descriptors 
and properties discussed in previous paragraph, these 
are (binding) properties per molecular fragment defined 
by the MW (Da) or the HAC (number of atoms). It has 
been completely overlooked, that alternatively, BEI can 
be interpreted directly as a property, the direct measure 
of the binding of a 1 g sample of a substance. Accordingly, 
LE is a property—a direct measure of the binding of a 
mole of HAC.
LE was originally developed in order to compare the 
maximal ligand-target affinity [13] including small, 
nonhydrogen ligand cations or anions. This, in turn, 
determined that non-hydrogen atom count, namely 
HAC, was the natural normalizing measure. However, 
the atom count (AC), hydrogen count or molecular 
weight can generate analog metrics. On the other hand, 
we can substantially broaden the LE definition to include 
any property (P) or molecular descriptor (MD). Thus, 
defining the efficiency parameter (PE or MDE), which for 
a property normalized versus HAC (as for a standard LE) 
will be defined by:
where  Pmol relates to a molar-normalized property, e.g. 
molar-binding affinity.
Data sets
The thermodynamic ∆G data of a series of 102 protein–
ligand complexes that interact with 14 different target 
classes were assembled by gathering bioactivity informa-
tion from the BindingDB database [9] by Reynolds and 
Holloway.
The catalog data for a commercial compound library of 
ca. 2.5 mln synthetic building blocks were downloaded 
from the internet site (http://www.abamachem.net/). This 
(1)LE = binding property/HAC
(1a)BEI = binding property/MW
(2)PEHAC = Pmol/HAC
large library includes 2,248,243 chemicals that are offered 
on the market [10]. The database contains easily accessi-
ble information that can be downloaded in the SDF for-
mat. The records were carefully inspected before further 
processing, e.g. duplicated notations were removed.
Calculations were performed using the KNIME Ana-
lytics Platform (version 3) on an Intel Core 2 Duo CPU 
1.80  GHz computer system with 4.00  GB RAM and a 
64-bit Windows 10 operating system. Instant JChem ver-
sion 14.7.28.0, which was released in 2014, and additional 
self-programmed scripts were used for structure data-
base management. Graphs were plotted using MATLAB 
version R2015b.
Results and discussion
In practice, LE is much more popular in drug design than 
BEI. Equation 2, which is the definition of LE, can be con-
verted to:
where  Pmol relates to a molar-normalized property, e.g. 
molar-binding affinity.
Equation  3 allows us to precisely understand the 
chemical sense of LE mapping. Accordingly,  PEHAC is the 
interaction of two terms. The first is  Pmol/MW, i.e.  Pmol 
normalized by MW. This term defines also BEI which 
is a possible LE alternative [12]. A second term MW/
HAC rescales BEI into the HAC dimension. To properly 
understand the operations described by Eqs. 2 and 3, we 
explained the fragmental (Fig.  1a), molar (Fig.  1b) and 
weight (Fig. 1c) metrics that are used to map atomic mol-
ecules (Fig. 1a) into a real substances (Fig. 1b, c) in chem-
istry. In order to calculate LE, we use fragmental metric 
(Fig.  1a) in an attempt to calculate the share of binding 
for a single Da (HAC fragment) in a single molecule 
(Fig.  1a) indicated in blue in Fig.  1. Mapping molecules 
to a mole of a substance, a mole metric (Fig. 1b), will pre-
serve the same number of molecules  (NA), but the weight 
of the samples of 1 mol will differ and amount to  MW1 
and  MW2 grams, respectively. Alternatively, mapping by 
weight metric will preserve the constant weight, e.g., 1 g. 
A surprising feature of the latter method of mapping is 
that the difference in a number of molecules in 1 g will be 
given by the numbers of  NA * 1/MW1 and  NA * 1/MW2, 
respectively. A surprise here comes from the fact that we 
are simply not accustomed to this metric. Although, we 
do not realize this fact, the weight metric is often used in 
medicinal chemistry, e.g. when measuring binding affin-
ity or  IC50  (Pgram), we test the weighted samples (g) in 
order to obtain the  Pgram in (kcal/g) and eventually, at the 
very end, recalculating the  Pgram into the  Pmol scale.
In turn, because binding affinities are given in the lit-
erature as  Pmol, therefore,  Pgram can be calculated from 
(3)PEHAC = Pmol/MW ∗MW/HAC
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the simple equation  Pgram = Pmol/MW, which essentially 
looks the same as the first term in Eq. 3, however, frag-
mental descriptor refers to a single molecule, while bind-
ing affinity refers to a substance. Although formally we 
need the Avogadro number  NA to relate the measured 
affinity and the affinity of a single molecule (or single 
fragment), we can do without  NA because the MW (Da) 
(molecular descriptor) and the mole of a substance MW 
(g/mol) (a property) are the same values.
The most interesting features of the metrics in Fig.  1 
are that:
1. All three measures in Fig. 1 preserve a steady invari-
able size of the 1 Da fragment
2. Unlike the molar measure  (Pmol), the weight metric, 
LE (BEI), does not have a thermodynamic meaning 
because the concentration of ligands is not normal-
ized for the molecules of different sizes and
3. The multiplier, which scales a molecule to a constant 
weight is proportional to 1/MW.
Generally, LE (BEI) is interpreted in the literature as a 
molecular physicochemical descriptor that relates to a sin-
gle molecule. This appears to be the main misunderstand-
ing because both the concentration and the binding are 
statistical properties that are related to molecular popula-
tions. Accordingly, LE (BEI) are also properties. The con-
centration here determines a population of the ligands 
that are available for the receptor to form ligand-receptor 
complexes, while  Pmol determines binding potency.
The trend of binding efficiency versus molecular descriptor 
and economic price
In Fig. 2a, c we plotted the BEI and  LEHAC for the thermo-
dynamic ∆G data of a series of ligands that interact with 
14 different target classes, which were extracted from 
the BindingDB database by Reynolds and Holloway [9], 
respectively. We can see that a hyperbole approximates 
the data for BEI. The large differentiation of the targets 
means that deviations from the model can be observed; 
however, the trend is obvious.
In order to become more familiar with the LE type 
metrics in Table  1, we analyzed the impact of the indi-
vidual terms of Eq. 3 to illustrate their chemical meaning 
and mathematics. Therefore, Eq.  3 can be decomposed 
into Eq. 3a:
 
Accordingly,  PEHAC is now the interaction of three 
terms. The first term is molar property, second is 1/
MW—a number of molecules in a 1  g sample of mole-
cules of the weight MW (Da) (a population term) and a 
third term, the MW to HAC rescaling factor. Essentially, 
the population term 1/MW dominates the real molar 
property  Pmol and the MW to HAC rescaling factor is 
more or less a constant value as MW versus HAC has a 
close to linear relationship for the thermodynamic ∆G 
data analyzed in this publication. Therefore, the popu-
lation term 1/MW and not a real property explains the 
trend of LE, thereby solving the puzzle of LE behavior. 
This determines a significant increase of LE for a small 
MW and a plateau for a high MW.
We could conclude at this point that the chemistry of 
LE behavior is trivial. In our opinion it is not the case, and 
it is not a coincidence that LE has been misinterpreted in 
significant articles in high impact journals (PNAS [13], 
Nature Reviews Drugs Discovery [1]). We can better 
understand the origins of this delusion by probing the LE 
models for nonbinding parameters.
First, problem is to identify such models. The relation-
ship between a chemical structure and its physical or 
chemical properties is an essential concept in chemistry 
and this method is an important decision-making guide, 
for example, in drug design. In fact however, it is the 
(3a)PEHAC = Pmol ∗ 1/MW ∗MW/HAC
Fig. 1 Avogadro statistics—two molecules,  MW1 (Da) and  MW2 (Da), a can be scaled to a substance and can agglomerate  NA molecules using mole 
metrics. The weight of the substances will be  MW1 (g/mol) and  MW2 (g/mol), respectively (b). Alternatively, mapping c can be performed in order 
to maintain a steady substance weight, e.g. of 1 g, and then the number of molecules will be different for two molecules each time and will have a 
value of 1/MW1 and 1/MW2, respectively. A virtual 1 (Da) fragment is indicated in blue
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market that eventually decides the success of any phar-
maceutical; therefore; we need economic considerations 
to fully understand a fate of a drug. Economic behav-
ior, in particular, a price of a drug is an example of the 
nonbinding parameter important for molecular design. 
Is there any relationship between a chemical structure 
of a drug and its economic potential? On the one hand, 
explaining economic effects is an extremely complex 
issue. On the other hand little market data is available for 
drugs. Accordingly, the problem remains unexplored. In 
contrast, to drugs a variety of economic data are available 
for other chemicals. Therefore, in Fig. 3a–d, we present a 
structure-economy analysis for a commercial compound 
library of ca. 2.5 mln synthetic building blocks [10]. It 
is critical to note that the price, which is an economic 
property, is typically listed in the catalogs of chemi-
cal compounds in $/g (Fig.  3a) and not $/mol (Fig.  3c), 
which means the efficiency scale is standard in econom-
ics. The relationships observed in Figs  3a, c determines 
market behavior of a large quantity of chemicals. This 
decides that instead of a single model a bunch of linear 
plots can be identified in Fig. 3c relating molar prices to 
MW, while weight prices (Fig. 3a) form a series of hori-
zontal plots, i.e., within each individual plot weight price 
does not depend upon MW (Fig.  3a). To further inves-
tigate the price data in Fig.  3b, d, we illustrated their 
MW binned statistics. This indicates that in economics 
the price of a sample normalized by weight is on aver-
age unvarying across a large range of MWs, while mean 
molar price forms a linear plot versus MW. Accordingly, 
with a decreasing MW, on average, we can get a larger 
number of molecules at the same price. Instead, if nor-
malized to the molar metric, the same fragments are 
cheaper at smaller MWs. Interestingly, even now the plot 
of the mean price (the LE type parameter) versus MW 
indicates a drop of prices at the low MWs, which can be 
interpreted as a hyperbolic like trend (Fig. 3b). However, 
this effect can be observed only within the lowest MW 
range, despite the fact that the molar and weight met-
rics are in a similar mathematical relation as the binding 
properties, i.e. the price $/g is given by the interaction of 
the molar price and 1/MW. Mean molar price is more or 
less a linear function of MW (Fig. 3d) or in other words, 
an increase of MW also means an increase of the weight 
Fig. 2 The binding ΔG values plotted versus MW or HAC—a BEI versus MW (black) versus a hyperbole 8 * 1/MW (red), c LE versus HAC (black) 
versus hyperbole 8 * 1/HAC (red), d delta G versus MW compared to b MW versus HAC (black) or MW/HAC versus HAC (red), data according to Ref. 
[9]; hyperboles plotted without optimization
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of a sample to be paid. The larger the quantity of weight, 
the larger is also the price, which is one of the essential 
rules of economics. Accordingly, a comparison of the 
binding versus economic LE data type illustrates that the 
understanding of important chemical effect is required to 
understand the LE trends versus molecular size. While 
Table 1 Chemical meaning and mathematical function of the individual terms that define LE (Eq. 3a)
No. Chemistry Mathematics Remarks
1 Molar property
NA molecules, of the total weight MW 
grams.







NA virtual fragments of the weight 1 Da
or













3. MW to HAC rescaling term
This can be a 
linear plot, as 
shown, but can  




Data according to Ref. [9]
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Fig. 3 Selected descriptors of the ca. 2.5 mln library data for chemical compounds according to Ref. [10]. a–d Market prices plotted versus MW a 
weight price ($/g) versus MW, b binned statistics of mean price ($/g) versus MW bin, c molar price ($/mol) versus MW, d binned statistics of mean 
molar price ($/mol) versus MW bin. Selected efficiency descriptors (e–g): e MW/HAC versus HAC, f Br/AC versus AC, g molar BrC versus MW
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the stoichiometry of ligand-target pairing limits the bind-
ing LE, the macroscopic weight determines the price. 
Unlike binding, pricing is not a statistical property; there-
fore, hypothetically, the price can tag a single molecule.
Recently, ratio type descriptors have been used more 
frequently in drug design [14]. This includes parameters 
such as ratio of O/(N + O) [14] or the number of molecu-
lar fragments, e.g. a fraction of sp3 carbons to all of the 
carbon atoms [15]. Therefore, in Fig.  3e–g, we present 
several molecular descriptors which show the molar and 
weight normalization, respectively, and was calculated for 
a large chemical compound library of ca. 2.5 mln chemical 
compounds. The first is a simple example, i.e. MW/HAC 
versus HAC (Fig.  3e). In particular, we can observe that 
MW versus HAC does not always have a linear relation-
ship. In turn, Fig. 3f shows a plot of the number of arbi-
trarily selected atoms, e.g., bromines (Br count; BrC), that 
was normalized by the atom count (AC), i.e. the  BrCAC 
(Br/AC) within this library. The individual hyperbo-
les map the molecules that have the same number of Br 
atoms. A question now arises of whether we can identify 
any chemical property that scales acc. to the weight met-
ric. The answer is positive because we can discover that 
a simple analytical attribute of the percentage content 
follows this metric. In turn, if we probe a relationship of 
bromine count BrC versus MW, then, BrC will take an 
integer value indicating bromine atoms in a single mole-
cule, which obeys a molar scale rule as is shown in Fig. 3g. 
Molecular descriptors and properties of the efficiency 
type can support us in illustrating various chemical and 
pharmaceutical effects. The nonlinearity of the hyperbolic 
population term is of potential interest in modeling in 
pharma and chemistry. However, this requires a complete 
understanding of the metrics that are used and the chemi-
cal effects that determine these metrics.
Conclusion
In conclusion, in this paper, the chemical meaning and 
mathematical form of ligand efficiency (LE) type data is 
explained. Therefore, LE is related to binding per gram 
(property) while the puzzle of the surprising behavior of 
LE is explained by the 1/MW dependency of the weight 
metric. We analyzed how this influences the weight-nor-
malized data for economic and molecular property and 
descriptor data.
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